Literature DB >> 18724295

The US National Marrow Donor Program role in unrelated donor hematopoietic cell transplantation.

D Confer1, P Robinett.   

Abstract

The National Marrow Donor Program (NMDP) is headquartered in Minneapolis, Minnesota, USA. Established in 1986, the NMDP currently operates the world's largest registry of unrelated adult donors and umbilical cord blood (UCB) units. Since its inception, the NMDP has benefited from continuous financial support provided by the US government through a series of contracts and grant awards. This funding has supported a large network of donor centers and the recruitment of millions of potential adult hematopoietic cell (HC) donors. More recently, the federal government has also supported a national registry for UCB units and expansion of the available UCB inventories. Today, the NMDP registry lists more than 6.7 million adult donors and 68,000 UCB units. Seventy-seven percent (5.2 million) of the adult donors and virtually all of the UCB units are fully typed for HLA A, B and DR. An additional 5 million donors are available for search through international collaborations. The NMDP currently facilitates more than 3600 recipients each year totaling more than 29,000 transplants since 1987.

Entities:  

Mesh:

Year:  2008        PMID: 18724295     DOI: 10.1038/bmt.2008.102

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  10 in total

1.  Safeguarding the long-term health of hematopoietic stem cell donors: a continuous and evolving process to maintain donor safety and trust.

Authors:  David Stroncek; Jeffrey McCullough
Journal:  Expert Rev Hematol       Date:  2012-02       Impact factor: 2.929

2.  Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007.

Authors:  Syed O A Ahmed; Ardeshir Ghavamzadeh; Syed Z Zaidi; Helen Baldomero; Marcelo C Pasquini; Fazal Hussain; Kamran Alimoghaddam; Fahad Almohareb; Mouhab Ayas; Amir Hamidieh; Hossam K Mahmoud; Alaa Elhaddad; Tarek Ben Othman; Abdelrahman Abdelkefi; Mahmoud Sarhan; Fawzi Abdel-Rahman; Salman Adil; Salam Alkindi; Ali Bazarbachi; Said Benchekroun; Dietger Niederwieser; Mary Horowitz; Alois Gratwohl; Hassan El Solh; Mahmoud Aljurf
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-01       Impact factor: 5.742

Review 3.  How I treat: the selection and acquisition of unrelated cord blood grafts.

Authors:  Juliet N Barker; Courtney Byam; Andromachi Scaradavou
Journal:  Blood       Date:  2010-12-13       Impact factor: 22.113

4.  Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.

Authors:  Juliet N Barker; Courtney E Byam; Nancy A Kernan; Sinda S Lee; Rebecca M Hawke; Kathleen A Doshi; Deborah S Wells; Glenn Heller; Esperanza B Papadopoulos; Andromachi Scaradavou; James W Young; Marcel R M van den Brink
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-25       Impact factor: 5.742

5.  Oral care in Brazilian bone marrow transplant centers.

Authors:  Fernanda de Paula Eduardo; Letícia Mello Bezinelli; Nelson Hamerschlak; Claudia Toledo Andrade; Leonardo Raul Morelli; Luciana Corrêa
Journal:  Rev Bras Hematol Hemoter       Date:  2011

6.  Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study.

Authors:  Alois Gratwohl; Helen Baldomero; Michael Gratwohl; Mahmoud Aljurf; Luis Fernando Bouzas; Mary Horowitz; Yoshihisa Kodera; Jeff Lipton; Minako Iida; Marcelo C Pasquini; Jakob Passweg; Jeff Szer; Alejandro Madrigal; Karl Frauendorfer; Dietger Niederwieser
Journal:  Haematologica       Date:  2013-03-18       Impact factor: 9.941

7.  Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer.

Authors:  Joshua A Roth; Mark E Bensink; Paul V O'Donnell; Ephraim J Fuchs; Mary Eapen; Scott D Ramsey
Journal:  J Comp Eff Res       Date:  2014-03       Impact factor: 1.744

8.  Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal Cells.

Authors:  Leland Metheny; Saada Eid; Karen Lingas; Jane Reese; Howard Meyerson; Alexander Tong; Marcos de Lima; Alex Y Huang
Journal:  Hematol Med Oncol       Date:  2016-10-20

Review 9.  Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow-Review of Published Literature.

Authors:  Shatha Farhan; Edward Peres; Nalini Janakiraman
Journal:  Adv Hematol       Date:  2016-03-28

Review 10.  Alternative Donor Transplantation for Acute Myeloid Leukemia.

Authors:  Nelli Bejanyan; Housam Haddad; Claudio Brunstein
Journal:  J Clin Med       Date:  2015-06-09       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.